ESMO: Roche, after Tecentriq’s ovarian cancer fail, banks hopes on final survival analysis aliu Sun, 09/20/2020 – 07:45

ESMO: Merck’s Keytruda doubles 5-year survival rate for lung cancer patients chelfand Mon, 09/21/2020 – 02:00

FiercePharmaPolitics—White House, pharma pricing talks fell apart over demand for ‘Trump Cards’: NYT esagonowsky Mon, 09/21/2020 – 09:51

Chinese customs raids J&J CAR-T partner Legend’s office, puts new CEO under ‘residential surveillance’ aliu Mon, 09/21/2020 – […]

ESMO: Merck’s Keytruda pushes for 2nd esophageal cancer nod with first-line survival win chelfand Mon, 09/21/2020 – 12:25

Post-operative radiotherapy (PORT) used in patients with non-small-cell lung cancer (NSCLC) following complete resection and after (neo) adjuvant […]

Despite the important advances in research in recent years, the etiopathogenesis of Alzheimer’s disease is still not fully […]

Minal Singh describes her career in dermatology as someone else’s fault. “I completed a two week placement during […]

Positive opinions include Pacira’s Exparel and two new vaccines from Sanofi

Detailed results presented at ESMO also show benefit in prostate cancer